First Tracks Biotherapeutics, Inc. (TRAX)
44.46
-0.65
(-1.44%)
USD |
NASDAQ |
Aug 26, 10:56
First Tracks Biotherapeutics Shareholders Equity (Quarterly) : 168.80M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 168.80M |
| Date | Value |
|---|---|
| March 31, 2026 | 257.46M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Forte Biosciences, Inc. | 183.79M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Agenus, Inc. | -199.08M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Amgen, Inc. | 11.69B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.14M |
| Total Liabilities (Quarterly) | 14.34M |
| Debt to Equity Ratio | 0.0257 |
| Current Ratio | 14.28 |
| Net Debt Paydown Yield | -0.15% |